Pre-Seed, Seed
$100K – $1.0M
17+ companies
2 partners
Investment Thesis
Midwest regional specialist backing bioscience startups from formation through seed, with strong ties to translational science, life sciences tools, and early company building. Often invests in science-first companies before larger coastal firms engage.
Meet the Team
Sach Chitnis
General Partner, Jump Capital
Donn Rubin
Founder
Industry Focus
Invests In
Portfolio Companies (17)
Other
Confluence Life Sciences
Peptyde Bio
Wugen
Engineers natural killer (NK) cell therapies for cancer.
CoverCress
Develops high-yield cover crops from mustard plants for sustainable agriculture.
Benson Hill
Uses AI and genomics for crop improvement and sustainable food ingredients.
Canopy Biosciences
Provides spatial biology tools for research and drug discovery.
Galera Therapeutics
Develops superoxide dismutase mimetics to protect healthy tissue during radiation therapy.
MediBeacon
Develops fluorescent imaging agents for kidney function diagnostics.
Arch Oncology
Engineers antibodies targeting KIF18A for cancer treatment.
Cardialen
Develops low-energy defibrillation therapy for cardiac arrhythmias.
- •Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, Other, SaaS — the sectors they actively back.
- •Size your ask to their typical $100K – $1.0M check.
- •cold outreach ok
- •Address your outreach to a specific partner, such as Sach Chitnis, General Partner, Jump Capital.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if BioGenerator Ventures is a match for your startup
Upload your pitch deck to see how well you match with BioGenerator Ventures and 10,000+ other investors.
Is this your profile? Request a correction or removal